OpenAI Offers Rosalind Academic Plan to US Labs

OpenAI said on 15 October 2026 that it is launching the Rosalind Academic Plan, a sponsored-access programme that gives eligible academic research labs access to GPT-Rosalind, its dedicated life-sciences model, together with the Rosalind workbench for tool orchestration across medicinal chemistry, genomics, wet-lab assistance and related scientific applications.

The company’s own wording is precise on what is free and what still needs approval: “Eligible labs can receive up to 30 Business Standard seats at no cost for up to 12 months, with access to GPT-Rosalind subject to trusted-access approval.”

What the plan includes

According to OpenAI’s announcement, eligible labs receive:

Up to 30 Business Standard seats at $0 per user per month for up to 12 months
Access to commercially available frontier OpenAI models, subject to plan usage limits
Access to GPT-Rosalind after trusted-access approval

OpenAI also states that research data shared through the Rosalind Academic Plan is “not used to train our models by default.”

API access is not included at this time, the same page says. Principal investigators (PIs) and lab leads who are approved manage member permissions and remain responsible for their lab’s approved use.

Who can apply

The plan is currently available to academic labs at US universities. OpenAI distinguishes two paths:

Labs at universities without an existing OpenAI Enterprise agreement apply through the trusted-access process on behalf of the lab.
Labs at universities with an existing Enterprise agreement must apply through their university’s Enterprise access process.

Before activation, OpenAI says it verifies institutional legitimacy and the PI or lab lead’s identity, reviews the lead’s background and authority, assesses the lab’s affiliation and intended use, and establishes responsibilities for the lab lead and a designated institutional safety contact. Monitoring and enforcement continue after activation; for registered high-sensitivity use cases, safety checks are meant to account for the approved research context.

What GPT-Rosalind is for

OpenAI positions GPT-Rosalind as a specialised life-sciences model for deeper reasoning on biological questions, used under trusted access within safeguards designed for legitimate research. Application areas listed on the page include drug and protein design, disease detection and monitoring, vaccines and immune responses, genetic and RNA therapies, agriculture and animal health, ecology and conservation, and antimicrobial resistance.

The announcement also quotes researchers already exploring the model — including Zhao Lab at UCSF, Dr Mathieu Bourdenx, and Dr Brian Hie (Stanford University and Arc Institute) — on literature exploration, drug-parameter gathering and scaling discovery tasks. Those are attributed researcher statements in OpenAI’s marketing copy, not independent TSN interviews.

Why it matters

Frontier multimodal and reasoning models are already leaking into wet-lab and computational biology workflows through consumer and enterprise ChatGPT seats. A named academic SKU with zero-dollar seats, a default no-training stance on research data, and an explicit trusted-access gate for a biology-specialised model is OpenAI’s attempt to put that use on a sponsored, reviewable path — while keeping API access off the table for now.

For UK and EU labs, the geographic limit matters: the page says the plan is currently for US universities only. International groups that want comparable access will need either a different OpenAI commercial path or to watch for a later expansion that this announcement does not promise.

What’s still unknown

How many labs will be approved in the first cohort, and typical turnaround time for trusted-access review
Exact usage limits on the bundled frontier models
Whether “not used to train by default” can be changed by a lab, and under what notice
Any timeline for non-US universities or for including API access

What to watch

Watch OpenAI’s help-centre eligibility guide and any Enterprise admin notices for universities that already have agreements. Also watch whether Rosalind workbench connectors (chemistry, genomics, LIMS-style tools) expand beyond the categories named in the launch post.

What this means

Sponsored academic seats. Up to 30 Business Standard seats free for up to 12 months, per OpenAI.
GPT-Rosalind still needs trusted-access approval. The free seats alone do not unlock the life-sciences model.
US universities only for now; no API. Geographic and API limits are explicit in the announcement.